Daniel Mair

发表

The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity

M. Beltramello, A. Telenti, R. Spreafico, 2020, bioRxiv.

Development of reverse genetics systems and investigation of host response antagonism and reassortment potential for Cache Valley and Kairi viruses, two emerging orthobunyaviruses of the Americas

S. Higgs, G. Wilkie, J. Hughes, 2018, PLoS neglected tropical diseases.

Epidemic waves of COVID-19 in Scotland: a genomic perspective on the impact of the introduction and relaxation of lockdown on SARS-CoV-2

A. Rambaut, R. Kao, M. Woolhouse, 2021, medRxiv.

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

Darren L. Smith, Evelien M. Adriaenssens, Gemma L. Kay, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

M. Beltramello, J. Chodera, A. Telenti, 2021, Cell.

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

Joshua B. Singer, Darren L. Smith, Shane A. McCarthy, 2021, The Lancet Infectious Diseases.

In vitro evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2

Arvind H. Patel, R. Orton, A. Kohl, 2021, bioRxiv.

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

William T. Harvey, Scott M Elliott, Robert M. Davies, 2022, Nature Microbiology.

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant

Graham W. Taylor, Joshua B. Singer, Darren L. Smith, 2021, Science.

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

D. A. Jackson, Graham W. Taylor, William L. Hamilton, 2020, Cell.

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Graham W. Taylor, Joshua B. Singer, Scott M Elliott, 2021, Nature.

SARS-CoV-2 evolution during treatment of chronic infection

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland

Joshua B. Singer, A. Rambaut, D. Robertson, 2020, Nature Microbiology.

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

William T. Harvey, Graham W. Taylor, William L. Hamilton, 2021, Cell Reports.

Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units – A high risk community-hospital interface

J. Hughes, P. Mark, S. McDonald, 2021, Journal of Infection.

Long-term adaptation following influenza A virus host shifts results in increased within-host viral fitness due to higher replication rates, broader dissemination within the respiratory epithelium and reduced tissue damage

P. Murcia, F. Marchesi, L. Martínez-Sobrido, 2021, PLoS pathogens.

Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning

William T. Harvey, Scott M Elliott, Kevin R. Cole, 2022, Scientific Reports.

A polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages

S. Tishkoff, S. Fan, J. McLauchlan, 2018, bioRxiv.

Development of a Reverse Genetics System for Toscana Virus (Lineage A)

G. Wilkie, A. Kohl, J. Dunlop, 2020, Viruses.

Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission

Graham W. Taylor, Scott M Elliott, Jaime M. Tovar-Corona, 2022, Nature Communications.

Genomic reconstruction of the SARS-CoV-2 epidemic in England

William T. Harvey, William L. Hamilton, Richard J. Goater, 2021, Nature.

In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2

N. Suárez, R. Orton, A. Kohl, 2021, PLoS pathogens.

SARS-CoV-2 evolution during treatment of chronic infection

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

Genomic epidemiology of SARS-CoV-2 spread in Scotland highlights the role of European travel in COVID-19 emergence

Joshua B. Singer, A. Rambaut, J. Hughes, 2020, medRxiv.

Author Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland

A. Rambaut, D. Robertson, J. Hughes, 2020, Nature Microbiology.

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

D. Robertson, J. Hughes, D. Alessi, 2021, PLoS biology.

Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

William T. Harvey, Scott M Elliott, Kevin R. Cole, 2023, Journal of Hospital Infection.

Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

William T. Harvey, Scott M Elliott, Robert M. Davies, 2022, Nature Microbiology.

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

A Polymorphic Residue That Attenuates Interferon Lambda 4 Activity in Hominid Lineages

S. Tishkoff, K. Garcia, S. Fan, 2018 .

of Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

D. A. Jackson, Graham W. Taylor, William L. Hamilton, 2021 .

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Joshua B. Singer, David A. Drew, Scott M Elliott, 2021, The Lancet. Public health.

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

M. Beltramello, J. Chodera, A. Telenti, 2021, Cell.

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

Scott M Elliott, Kevin R. Cole, Robert M. Davies, 2022, Scientific Reports.